Two fragments of bovine GH, obtained by dissociation of a limited tryptic digest of the hormone, were examined for several activities which have been associated with somatomedin. The activities evaluated were: 1) the in vitro uptake of [35S]sulfate and [3H]thymidine incorporation into DNA of cartilage segments of hypophysectomized rats and 2) the competition with [125I]iodo-insulin for insulin-binding sites of a particulate human placental membrane preparation. The smaller fragment, A-II, stimulated sulfation and DNA synthesis, and competed with insulin. The larger fragment, A-I, at a concentration of 1 × 10-7 M, enhanced DNA synthesis but did not affect sulfate uptake. A-I competed with insulin but not as effectively as A-II. Bovine GH, at the concentrations tested, did not affect sulfation or DNA synthesis. It did compete with insulin binding but not as effectively as A-II. The in vitro responses observed with both A-I and A-II were not parallel to those found with normal human serum, nor was the overall stimulation as great. The minimum effective concentrations of A-II for stimulating sulfation and DNA synthesis were 4 × 10-10 M and 4.5 × 10-8 M, respectively. These studies suggest that A-II (fragment 96–133 of bGH) possesses several activities (sulfation, DNA synthesis, and insulin competition) which are somatomedin-like. That A-I, like A-II, stimulated DNA synthesis and competed for insulin-binding sites is consistent with the suggestion that the GH molecule may have more than one “active site.”
No takes yet. Share an insight, caveat, or question.
Liberti et al. (1978) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: